146 related articles for article (PubMed ID: 10703540)
1. Efficacy of long-term growth hormone treatment in Turner's syndrome. European Study Group.
Van den Broeck J; Van Teunenbroek A; Hokken-Koelega A; Wit JM
J Pediatr Endocrinol Metab; 1999; 12(5):673-6. PubMed ID: 10703540
[TBL] [Abstract][Full Text] [Related]
2. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
3. Final height after long-term growth hormone treatment in Turner syndrome. European Study Group.
Van den Broeck J; Massa GG; Attanasio A; Matranga A; Chaussain JL; Price DA; Aarskog D; Wit JM
J Pediatr; 1995 Nov; 127(5):729-35. PubMed ID: 7472824
[TBL] [Abstract][Full Text] [Related]
4. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
5. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
Rosenfeld RG
Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
[TBL] [Abstract][Full Text] [Related]
7. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.
Reiter EO; Blethen SL; Baptista J; Price L
J Clin Endocrinol Metab; 2001 May; 86(5):1936-41. PubMed ID: 11344188
[TBL] [Abstract][Full Text] [Related]
8. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
[TBL] [Abstract][Full Text] [Related]
9. Does growth-hormone supplementation affect adult height in Turner's syndrome?
Taback SP; Collu R; Deal CL; Guyda HJ; Salisbury S; Dean HJ; Van Vliet G
Lancet; 1996 Jul; 348(9019):25-7. PubMed ID: 8691926
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height.
Rosenfeld RG; Attie KM; Frane J; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM; Mahoney CP; Moore WV; Saenger P; Johanson AJ
J Pediatr; 1998 Feb; 132(2):319-24. PubMed ID: 9506648
[TBL] [Abstract][Full Text] [Related]
11. [Possibilities to increase the efficacy of growth hormone therapy in Turner syndrome].
Ságodi L; Sólyom E
Orv Hetil; 1997 Jun; 138(23):1501-5. PubMed ID: 9254366
[TBL] [Abstract][Full Text] [Related]
12. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
13. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
14. Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome.
Chu CE; Paterson WF; Kelnar CJ; Smail PJ; Greene SA; Donaldson MD
Acta Paediatr; 1997 Feb; 86(2):160-4. PubMed ID: 9055885
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials of GH treatment in patients with Turner's syndrome in Japan--a consideration of final height. The Committee for the Treatment of Turner's Syndrome.
Takano K; Ogawa M; Tanaka T; Tachibana K; Fujita K; Hizuka N
Eur J Endocrinol; 1997 Aug; 137(2):138-45. PubMed ID: 9272101
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
[TBL] [Abstract][Full Text] [Related]
17. Recombinant growth hormone in children and adolescents with Turner syndrome.
Cave CB; Bryant J; Milne R
Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
[TBL] [Abstract][Full Text] [Related]
18. Three years of GH treatment in Turner's syndrome: complex effect of GH dosage on growth parameters. French Pediatric Clinics and Sanofi-Winthrop.
Bertrand AM; Chaussain JL; Job B; Mariani R; Ponte C; Rappaport R; Rochiccioll P; Chatelain P
Clin Endocrinol (Oxf); 1996 Jun; 44(6):665-71. PubMed ID: 8759178
[TBL] [Abstract][Full Text] [Related]
19. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
[TBL] [Abstract][Full Text] [Related]
20. [Growth hormone for Turner's syndrome].
Fishman A; Hochberg Z
Harefuah; 1991 Nov; 121(9):281-6. PubMed ID: 1800273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
